E-Folder - Business

If you are not using the 80/20 Principle to control your strategy, your strategy is more than likely wrong. You may not have

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

an accurate picture of where you make, and lose, the most money.

Where are you making the most money?

Condu

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

t an 80/20 Analysis of profits by different categories of your business:

by product or product group/type
by customer or

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

customer group/type
by any other split which appears to be relevant for your business
by competitive segment

Look

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

t the sales over a given period and then determine the profit of each after allocating all of the cost for each group/type. B

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

careful when allocating the cost as each product will be different and have more or less activity from sales, manufacturing,

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

etc.

When correctly allocating the cost to each product, you will usually find that some are making most of the profit and so

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e are accounting for most of the losses, with the rest falling somewhere in between.

After products, go on to look at each cu

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

stomer, some will be willing to pay more but require a higher cost to service. Follow the same analysis for the remaining gro

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

p/types that you have identified.

Now with all the information at hand divide your business up into segments and what product

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

they use and determine the return on sales for each. Find the closest top 20% and the closest bottom 20%.

What acti

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ons should you take on this Analysis?

Before you take any action, know what the results will be. Will reducing the

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

esources for one segment have any affect on another segment that is showing a profit? Discuss the changes with all department

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

s to be sure that everyone is on board and that you have not overlooked anything. If a segment is losing money but improving

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ou may want to give it time before shifting resources to a more profitable segment List each segment and assign a priority, d

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

scribe the characteristic and the proposed actions for each segment.

Your goal should be to start with an 80/20 profit analys

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

is and determine a segment strategy. Continue to refine your results and redirect your efforts to the areas where you can ga

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

n the most benefit. There will always be an 80/20 relationship between the group/types in your business, and there will alway

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

s be room for improvement. The work will never be complete.

Sugested reading: The 80/20 Principle, by Richard Koch, ISBN 0-3

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

5-49174-3

Think of an example from your business where the 80/20 Analysis might result in strategy for improvement in profits

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/44445/e-folder-Is-Your-Strategy-Wrong.html">Is Your Strategy Wrong?</a>

BB link (for phorums):
[url=http://www.e-folder.org.ua/article/44445/e-folder-Is-Your-Strategy-Wrong.html]Is Your Strategy Wrong?[/url]

What do you do when you think the people who you are using as job references may be giving a negative reference.

Call centers are becoming increasingly popular all over the world today, especially with companies now having a centralized customer service and support center. Call centers play a critical part in most modern companies, as they fulfill the need to create a strong link between a company and its customers. A call center is basically an office where inbound calls to the company are accepted and where outbound calls to customers and clients are made. Call centers are usually categorized into two types: inbound call centers and outbound call centers.

What such managers often have in common is a single-minded preoccupation with simple tactics like press releases, broadcast plugs, special events and brochures, which denies them the best that public relations has to offer.

Tags

Links

E-Folder - Is Your Strategy Wrong?

Related Articles: